BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Liver diseases
1
Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
6/20/2024 3:42:22 AM | Browse: 29 | Download: 46
2
Revolutionizing disease diagnosis and management: Open-access magnetic resonance imaging datasets a challenge for artificial intelligence driven liver iron quantification
6/4/2024 3:55:01 PM | Browse: 28 | Download: 67
3
Machine learning approaches using blood biomarkers in non-alcoholic fatty liver diseases
6/28/2022 9:38:07 AM | Browse: 405 | Download: 942
4
COVID-19 and liver diseases, what we know so far
4/30/2022 5:08:22 AM | Browse: 299 | Download: 473
5
COVID-19, liver dysfunction and pathophysiology: A conceptual discussion
2/9/2022 7:25:27 AM | Browse: 393 | Download: 785
6
Emerging artificial intelligence applications in liver magnetic resonance imaging
10/27/2021 7:14:11 AM | Browse: 429 | Download: 767
7
Liver and COVID-19: From care of patients with liver diseases to liver injury
10/22/2021 1:53:28 PM | Browse: 412 | Download: 765
8
Factors predicting futility of liver transplant in elderly recipients: A single-center experience
10/14/2021 9:37:43 AM | Browse: 539 | Download: 1025
9
Malnutrition and liver disease in a developing country
8/10/2021 6:48:42 AM | Browse: 460 | Download: 888
10
Liver dysfunction and SARS-CoV-2 infection
7/12/2021 12:42:13 AM | Browse: 523 | Download: 879
11
Viscoelastic tests in liver disease: where do we stand now?
6/18/2021 5:06:16 AM | Browse: 441 | Download: 825
12
Role of bile acids in liver diseases mediated by gut microbiome
6/8/2021 10:51:03 AM | Browse: 433 | Download: 1049
13
Bile acid indices as biomarkers for liver diseases I: Diagnostic markers
4/16/2021 10:13:42 AM | Browse: 461 | Download: 883
14
COVID-19 and co-morbidities of hepatic diseases in a global perspective
3/30/2021 7:03:44 AM | Browse: 489 | Download: 939
15
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
12/21/2020 12:21:52 PM | Browse: 619 | Download: 936
16
Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
11/24/2020 12:41:21 PM | Browse: 566 | Download: 1387
17
Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases
9/21/2020 4:02:08 PM | Browse: 577 | Download: 1317
18
Progress of intravoxel incoherent motion diffusion-weighted imaging in liver diseases
8/6/2020 9:52:05 AM | Browse: 673 | Download: 1071
19
Role of γδT cells in liver diseases and its relationship with intestinal microbiota
5/28/2020 1:08:01 PM | Browse: 931 | Download: 1442
20
Role of spleen tyrosine kinase in liver diseases
3/14/2020 3:03:29 PM | Browse: 876 | Download: 1164
21
Study on serum amyloid A levels in patients with liver diseases
11/21/2019 8:40:16 AM | Browse: 945 | Download: 1745
22
Organoids of liver diseases: From bench to bedside
4/25/2019 3:13:57 AM | Browse: 784 | Download: 1259
23
Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease
3/27/2019 10:37:20 AM | Browse: 873 | Download: 1328
24
Dental pulp cell bank as a possible future source of individual hepatocytes
10/27/2018 4:40:10 AM | Browse: 884 | Download: 1105
25
Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases: A field that needs to be closely studied
3/4/2018 12:36:47 PM | Browse: 943 | Download: 993
26
Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection
1/14/2018 5:07:58 AM | Browse: 987 | Download: 1103
27
Effect of silymarin on biochemical indicators in patients with liver disease: systematic review with meta-analysis
7/20/2017 10:12:50 AM | Browse: 1214 | Download: 1651
28
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
6/14/2017 9:25:57 AM | Browse: 1000 | Download: 1513
29
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis b- and c-related-hepatocellular-carcinoma
4/12/2016 1:04:00 PM | Browse: 1406 | Download: 2645
30
Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications
12/31/2015 1:27:00 PM | Browse: 1133 | Download: 1360
31
Cirrhosis in children and adolescents: An overview
12/2/2015 12:01:00 PM | Browse: 1340 | Download: 1626
32
Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis
8/28/2015 5:05:00 PM | Browse: 979 | Download: 1286
33
Insights into human immunodeficiency virus-hepatitis B virus co-infection in India
8/13/2015 10:30:00 AM | Browse: 952 | Download: 1373
34
Antioxidants in liver health
8/8/2015 1:27:00 PM | Browse: 1095 | Download: 2054
35
Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases
5/1/2015 7:01:00 PM | Browse: 876 | Download: 1164
36
Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: An update
3/30/2015 5:46:00 PM | Browse: 1244 | Download: 1497
37
Preliminary study of a new pathological evolution-based clinical hepatolithiasis classification
2/11/2015 4:38:00 PM | Browse: 1004 | Download: 1356
38
Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration
12/20/2014 9:24:00 PM | Browse: 1259 | Download: 1422
39
DNA methylation in liver diseases
12/8/2014 4:35:00 PM | Browse: 1049 | Download: 1317
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345